IBB vs SCHG
iShares Biotechnology ETF vs Schwab US Large-Cap Growth ETF
- • SCHG has the lower expense ratio at 0.04% vs 0.44% for IBB.
- • SCHG pays a higher dividend yield (0.39%).
Side-by-side metrics
| Metric | IBB | SCHG |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.44% | 0.04% |
Dividend yield Trailing 12-month yield. | 0.22% | 0.39% |
AUM Assets under management — bigger funds are typically more liquid. | $9.09B | $59.07B |
YTD return | 16.44% | 5.17% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.69 | 1.21 |
P/E ratio | 24.89 | 32.39 |
Last price | $197.34 | $34.54 |
Inception | — | — |
Issuer | iShares | Schwab |
IBB top holdings
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
SCHG top holdings
| NVDA | NVIDIA Corp | 10.02% |
| AAPL | Apple Inc | 8.78% |
| MSFT | Microsoft Corp | 5.81% |
| AMZN | Amazon.com Inc | 4.99% |
| GOOGL | Alphabet Inc Class A | 4.40% |
| AVGO | Broadcom Inc | 3.74% |
| GOOG | Alphabet Inc Class C | 3.52% |
| LLY | Eli Lilly and Co | 3.31% |
| AMD | Advanced Micro Devices Inc | 2.89% |
| TSLA | Tesla Inc | 2.82% |
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About SCHG
SCHG (Schwab US Large-Cap Growth ETF) is Large-cap US growth at low cost. Managed by Schwab, the fund carries $59.1B in assets under management, an expense ratio of 0.04%, a dividend yield of 0.39%. Its largest holding is NVIDIA Corp (NVDA), which represents 10.0% of the portfolio. Real Estate is the fund's largest sector exposure at 0.6%.